These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 951878)

  • 1. Treatment of bone disease in patients on chronic hemodialysis with dihydrotachysterol.
    Cordy PE
    Trans Am Soc Artif Intern Organs; 1976; 22():60-4. PubMed ID: 951878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of bone disease with dihydrotachysterol in patients undergoing long-term hemodialysis.
    Cordy PE
    Can Med Assoc J; 1977 Oct; 117(7):766-8. PubMed ID: 907948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evolving aspects of uremic osteodystrophy in the dialized patient].
    Zucchelli P; Fusaroli M; Fabbri L; Catizone L; Pavlica P; Viglietta G; Casanova S
    J Urol Nephrol (Paris); 1976; 82(4-5):325-8. PubMed ID: 940176
    [No Abstract]   [Full Text] [Related]  

  • 4. Hypophosphataemia and osteomalacia in haemodialysis patients not taking phosphate binders.
    Ahmed KY; Varghese Z; Meinhard EA; Baillod RA; Skinner RK; Wills MR; Moorhead JF
    Adv Exp Med Biol; 1977; 81():581-90. PubMed ID: 899942
    [No Abstract]   [Full Text] [Related]  

  • 5. [Renal osteopathy and bone mineralisation in patients treated with dihydrotachysterol during long term dialysis (author's transl)].
    Pogglitsch H; Schmidberger H; Gell G
    MMW Munch Med Wochenschr; 1976 Jan; 118(5):131-6. PubMed ID: 814443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary trials with 24,25-dihydroxyvitamin D3 in dialysis osteomalacia.
    Hodsman AB; Wong EG; Sherrard DJ; Brickman AS; Lee DB; Singer FR; Norman AW; Coburn JW
    Am J Med; 1983 Mar; 74(3):407-14. PubMed ID: 6338716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D compounds and renal osteodystrophy.
    Felsenfeld AJ; Llach F
    Int J Artif Organs; 1983 Nov; 6(6):281-4. PubMed ID: 6689416
    [No Abstract]   [Full Text] [Related]  

  • 8. Does strict phosphorus control precipitate renal osteomalacia?
    Delmez JA; Fallon MD; Harter HR; Hruska KA; Slatopolsky E; Teitelbaum SL
    J Clin Endocrinol Metab; 1986 Apr; 62(4):747-52. PubMed ID: 3949954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Azotemic renal osteodystrophy; clinical features and bone pathology.
    Suzuki M; Hirasawa Y
    Endocrinol Jpn; 1979 Jun; 26(Suppl):85-93. PubMed ID: 467354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent hypophosphataemia and osteomalacia in dialysis patients not on oral phosphate-binders: Response to dihydrotachysterol therapy.
    Ahmed KY; Varghese Z; Wills MR; Meinhard E; Skinner RK; Baillod RA; Moorhead JF
    Lancet; 1976 Aug; 2(7983):439-42. PubMed ID: 73742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of uremic osteopathy. Effects of vitamin D metabolites and vitamin D analogs in chronic uremia and experimental renal insufficiency].
    von Herrath D; Kraft D; Schaefer K; Krempien B
    MMW Munch Med Wochenschr; 1974 Sep; 116(37):1573-8. PubMed ID: 4374654
    [No Abstract]   [Full Text] [Related]  

  • 12. Bone disease in hemodialysis patients with particular reference to the effect of fluoride.
    Cordy PE; Gagnon R; Taves DR; Kaye M
    Can Med Assoc J; 1974 Jun; 110(12):1349-53. PubMed ID: 4834525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of renal osteodystrophy in children with dihydrotachysterol and 24,25-dihydroxyvitamin D3.
    van Diemen-Steenvoorde R; Donckerwolcke RA; Bosch R; Visser WJ; Raymakers JA; Duursma SA
    Clin Nephrol; 1985 Dec; 24(6):292-9. PubMed ID: 3878249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypophosphataemic osteomalacia in patients receiving haemodialysis.
    Mahony JF; Hayes JM; Ingham JP; Posen S
    Br Med J; 1976 Jul; 2(6028):142-4. PubMed ID: 1276833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of renal osteodystrophy].
    Duursma SA; Dorhout Mees EJ
    Ned Tijdschr Geneeskd; 1978 Mar; 122(11):373-8. PubMed ID: 634388
    [No Abstract]   [Full Text] [Related]  

  • 17. Dihydrotachysterol treatment in renal osteodystrophy; the effect on alkaline and acid phosphatase.
    Van Kesteren RG; Duursma SA; Dorhout Mees EJ
    Neth J Med; 1978; 21(1):17-22. PubMed ID: 634412
    [No Abstract]   [Full Text] [Related]  

  • 18. Serum alkaline phosphatase in azotemic and hemodialysis osteodystrophy: a study of isoenzyme patterns, their correlation with bone histology, and their changes in response to treatment with 1alphaOHD3 and 1,25(OH)2D3.
    Pierides AM; Skillen AW; Ellis HA
    J Lab Clin Med; 1979 Jun; 93(6):899-909. PubMed ID: 438610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of high calcium dialysate in the treatment of renal osteomalacia.
    Evans RA; Somerville PJ
    Aust N Z J Med; 1976 Feb; 6(1):10-5. PubMed ID: 1065293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteomalacic dialysis osteodystrophy: a trial of phosphate-enriched dialysis fluid.
    Feest TG; Ward MK; Ellis HA; Aljama P; Kerr DN
    Br Med J; 1978 Jan; 1(6104):18-20. PubMed ID: 620130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.